Authors : Manali Borse, Shubham Bagade, Atul Bendale, Laxmikant Borse, Anil Jadhav
DOI : 10.18231/j.ijcaap.2022.002
Volume : 7
Issue : 1
Year : 2022
Page No : 5-11
Because synthetic pharmaceuticals may produce various side effects and unfavorable consequences, the use of natural plants in therapy is currently more common than synthetic goods. Tecoma stans is a plant found in most tropical countries. This plant belongs to the Bignoniaceae family and is already used in ancient medicine in various countries such as India and Pakistan. This plant has a large number of active chemical ingredients and has pharmacological effects. Many researchers have explored pharmacological screening, and ongoing research is being conducted in that plant. The goal of this study was to update the plant's research collections for pharmacological screening. The review focuses on several researches, such as pharmacognostical studies and in-vitro and in-vivo screening of numorous Tecoma stans components. The various parts of the plants were concluded to have various pharmacological actions such as anti-inflammatory, analgesic, anticancer cardioprotective effect, genotoxic, cytotoxicity, wound healing, antihyperglycemic, protect CNS, gastric ulcer healing, antiproliferative, antioxidant, anti-microbial, haemolytic activity, anti-lipoxygenase, and acetyl-cholinesterase inhibitory activities. This review was then used to guide future study on this plant. A member of the trumpet vine family, Tecoma stans, has been documented for a variety of pharmacological properties. The current research focuses on the neuropharmacological activities of several Tecoma stans extracts. The CNS depressive action was addressed first, followed by the analgesic activity, and then the impact of various extracts on Albino mice was examined.
Keywords: Yellow trumpet flower, Flavanoids, CNS depressant activity, Neuropharmacology, Analgesic activity